Press Releases :: ProMIS Neurosciences, Inc. (PMN)

Nov 14, 2022 7:00am EST

ProMIS Neurosciences Announces Third Quarter 2022 Financial Results and Recent Highlights

Oct 12, 2022 7:00am EDT

ProMIS Neurosciences Announces Closing of US $7.4 Million Private Placement

Sep 13, 2022 7:00am EDT

ProMIS Neurosciences appoints accomplished biopharmaceutical leader, Dr. Gail M. Farfel, as Chief Executive Officer

Aug 15, 2022 5:00pm EDT

ProMIS Neurosciences Announces Second Quarter 2022 Financial and Operating Results

Aug 02, 2022 7:00am EDT

ProMIS Neurosciences Presents at 2022 Alzheimer’s Association International Conference

Jul 27, 2022 7:00am EDT

ProMIS Neurosciences to Present at 2022 Alzheimer’s Association International Conference

Jul 08, 2022 7:00am EDT

ProMIS Neurosciences to Commence Trading on Nasdaq Under the Symbol “PMN”

Jun 27, 2022 7:00am EDT

PROMIS ANNOUNCES REVERSE SHARE SPLIT TO MEET NASDAQ LISTING CRITERIA

Jun 22, 2022 7:00am EDT

ProMIS Neurosciences Announces Debt Amendment and Conversion

Jun 22, 2022 7:00am EDT

ProMIS Neurosciences Announces Filing of Form 10 Registration Statement and Nasdaq Listing Application

1
2
3
4
5
6
7
8
9
10
…19
arrow_forward